Pathogenesis of the novel autoimmune-associated long-QT syndrome

Yuankun Yue, Monica Castrichini, Ujala Srivastava, Frank Fabris, Krupa Shah, Zhiqiang Li, Yongxia Qu, Nabil El-Sherif, Zhengfeng Zhou, Craig January, M. Mahmood Hussain, Xian Cheng Jiang, Eric A. Sobie, Marie Wahren-Herlenius, Mohamed Chahine, Pier Leopoldo Capecchi, Franco Laghi-Pasini, Pietro Enea Lazzerini, Mohamed Boutjdir

    Research output: Research - peer-reviewArticle

    • 14 Citations

    Abstract

    Background - Emerging clinical evidence demonstrates high prevalence of QTc prolongation and complex ventricular arrhythmias in patients with anti-Ro antibody (anti-Ro Ab)-positive autoimmune diseases. We tested the hypothesis that anti-Ro Abs target the HERG (human ether-a-go-go-related gene) K+ channel, which conducts the rapidly activating delayed K+ current, IKr, thereby causing delayed repolarization seen as QT interval prolongation on the ECG. Methods and Results - Anti-Ro Ab-positive sera, purified IgG, and affinity-purified anti-52kDa Ro Abs from patients with autoimmune diseases and QTc prolongation were tested on IKr using HEK293 cells expressing HERG channel and native cardiac myocytes. Electrophysiological and biochemical data demonstrate that anti-Ro Abs inhibit IKr to prolong action potential duration by directly binding to the HERG channel protein. The 52-kDa Ro antigen-immunized Guinea pigs showed QTc prolongation on ECG after developing high titers of anti-Ro Abs, which inhibited native IKr and cross-reacted with Guinea pig ERG channel. Conclusions - The data establish that anti-Ro Abs from patients with autoimmune diseases inhibit IKr by cross-reacting with the HERG channel likely at the pore region where homology between anti-52-kDa Ro antigen and HERG channel is present. The animal model of autoimmune-associated QTc prolongation is the first to provide strong evidence for a pathogenic role of anti-Ro Abs in the development of QTc prolongation. It is proposed that adult patients with anti-Ro Abs may benefit from routine ECG screening and that those with QTc prolongation should receive counseling about drugs that may increase the risk for life-threatening arrhythmias.

    LanguageEnglish (US)
    Pages230-240
    Number of pages11
    JournalCirculation
    Volume132
    Issue number4
    DOIs
    StatePublished - Jul 28 2015

    Fingerprint

    Long QT Syndrome
    Autoimmune Diseases
    Electrocardiography
    Cardiac Arrhythmias
    Guinea Pigs
    SS-A antigen
    HEK293 Cells
    Cardiac Myocytes
    Ether
    Action Potentials
    Counseling
    Anti-Idiotypic Antibodies
    Animal Models
    Immunoglobulin G
    Serum
    Pharmaceutical Preparations
    Genes
    Proteins
    SS-A antibodies

    Keywords

    • antibodies
    • arrhythmias cardiac
    • immune system
    • long QT syndrome

    ASJC Scopus subject areas

    • Physiology (medical)
    • Cardiology and Cardiovascular Medicine
    • Medicine(all)

    Cite this

    Yue, Y., Castrichini, M., Srivastava, U., Fabris, F., Shah, K., Li, Z., ... Boutjdir, M. (2015). Pathogenesis of the novel autoimmune-associated long-QT syndrome. Circulation, 132(4), 230-240. DOI: 10.1161/CIRCULATIONAHA.115.009800

    Pathogenesis of the novel autoimmune-associated long-QT syndrome. / Yue, Yuankun; Castrichini, Monica; Srivastava, Ujala; Fabris, Frank; Shah, Krupa; Li, Zhiqiang; Qu, Yongxia; El-Sherif, Nabil; Zhou, Zhengfeng; January, Craig; Hussain, M. Mahmood; Jiang, Xian Cheng; Sobie, Eric A.; Wahren-Herlenius, Marie; Chahine, Mohamed; Capecchi, Pier Leopoldo; Laghi-Pasini, Franco; Lazzerini, Pietro Enea; Boutjdir, Mohamed.

    In: Circulation, Vol. 132, No. 4, 28.07.2015, p. 230-240.

    Research output: Research - peer-reviewArticle

    Yue, Y, Castrichini, M, Srivastava, U, Fabris, F, Shah, K, Li, Z, Qu, Y, El-Sherif, N, Zhou, Z, January, C, Hussain, MM, Jiang, XC, Sobie, EA, Wahren-Herlenius, M, Chahine, M, Capecchi, PL, Laghi-Pasini, F, Lazzerini, PE & Boutjdir, M 2015, 'Pathogenesis of the novel autoimmune-associated long-QT syndrome' Circulation, vol 132, no. 4, pp. 230-240. DOI: 10.1161/CIRCULATIONAHA.115.009800
    Yue Y, Castrichini M, Srivastava U, Fabris F, Shah K, Li Z et al. Pathogenesis of the novel autoimmune-associated long-QT syndrome. Circulation. 2015 Jul 28;132(4):230-240. Available from, DOI: 10.1161/CIRCULATIONAHA.115.009800
    Yue, Yuankun ; Castrichini, Monica ; Srivastava, Ujala ; Fabris, Frank ; Shah, Krupa ; Li, Zhiqiang ; Qu, Yongxia ; El-Sherif, Nabil ; Zhou, Zhengfeng ; January, Craig ; Hussain, M. Mahmood ; Jiang, Xian Cheng ; Sobie, Eric A. ; Wahren-Herlenius, Marie ; Chahine, Mohamed ; Capecchi, Pier Leopoldo ; Laghi-Pasini, Franco ; Lazzerini, Pietro Enea ; Boutjdir, Mohamed. / Pathogenesis of the novel autoimmune-associated long-QT syndrome. In: Circulation. 2015 ; Vol. 132, No. 4. pp. 230-240
    @article{fe19f09b59804d1daaff7b92954bfa5f,
    title = "Pathogenesis of the novel autoimmune-associated long-QT syndrome",
    abstract = "Background - Emerging clinical evidence demonstrates high prevalence of QTc prolongation and complex ventricular arrhythmias in patients with anti-Ro antibody (anti-Ro Ab)-positive autoimmune diseases. We tested the hypothesis that anti-Ro Abs target the HERG (human ether-a-go-go-related gene) K+ channel, which conducts the rapidly activating delayed K+ current, IKr, thereby causing delayed repolarization seen as QT interval prolongation on the ECG. Methods and Results - Anti-Ro Ab-positive sera, purified IgG, and affinity-purified anti-52kDa Ro Abs from patients with autoimmune diseases and QTc prolongation were tested on IKr using HEK293 cells expressing HERG channel and native cardiac myocytes. Electrophysiological and biochemical data demonstrate that anti-Ro Abs inhibit IKr to prolong action potential duration by directly binding to the HERG channel protein. The 52-kDa Ro antigen-immunized Guinea pigs showed QTc prolongation on ECG after developing high titers of anti-Ro Abs, which inhibited native IKr and cross-reacted with Guinea pig ERG channel. Conclusions - The data establish that anti-Ro Abs from patients with autoimmune diseases inhibit IKr by cross-reacting with the HERG channel likely at the pore region where homology between anti-52-kDa Ro antigen and HERG channel is present. The animal model of autoimmune-associated QTc prolongation is the first to provide strong evidence for a pathogenic role of anti-Ro Abs in the development of QTc prolongation. It is proposed that adult patients with anti-Ro Abs may benefit from routine ECG screening and that those with QTc prolongation should receive counseling about drugs that may increase the risk for life-threatening arrhythmias.",
    keywords = "antibodies, arrhythmias cardiac, immune system, long QT syndrome",
    author = "Yuankun Yue and Monica Castrichini and Ujala Srivastava and Frank Fabris and Krupa Shah and Zhiqiang Li and Yongxia Qu and Nabil El-Sherif and Zhengfeng Zhou and Craig January and Hussain, {M. Mahmood} and Jiang, {Xian Cheng} and Sobie, {Eric A.} and Marie Wahren-Herlenius and Mohamed Chahine and Capecchi, {Pier Leopoldo} and Franco Laghi-Pasini and Lazzerini, {Pietro Enea} and Mohamed Boutjdir",
    year = "2015",
    month = "7",
    doi = "10.1161/CIRCULATIONAHA.115.009800",
    volume = "132",
    pages = "230--240",
    journal = "Circulation",
    issn = "0009-7322",
    publisher = "Lippincott Williams and Wilkins",
    number = "4",

    }

    TY - JOUR

    T1 - Pathogenesis of the novel autoimmune-associated long-QT syndrome

    AU - Yue,Yuankun

    AU - Castrichini,Monica

    AU - Srivastava,Ujala

    AU - Fabris,Frank

    AU - Shah,Krupa

    AU - Li,Zhiqiang

    AU - Qu,Yongxia

    AU - El-Sherif,Nabil

    AU - Zhou,Zhengfeng

    AU - January,Craig

    AU - Hussain,M. Mahmood

    AU - Jiang,Xian Cheng

    AU - Sobie,Eric A.

    AU - Wahren-Herlenius,Marie

    AU - Chahine,Mohamed

    AU - Capecchi,Pier Leopoldo

    AU - Laghi-Pasini,Franco

    AU - Lazzerini,Pietro Enea

    AU - Boutjdir,Mohamed

    PY - 2015/7/28

    Y1 - 2015/7/28

    N2 - Background - Emerging clinical evidence demonstrates high prevalence of QTc prolongation and complex ventricular arrhythmias in patients with anti-Ro antibody (anti-Ro Ab)-positive autoimmune diseases. We tested the hypothesis that anti-Ro Abs target the HERG (human ether-a-go-go-related gene) K+ channel, which conducts the rapidly activating delayed K+ current, IKr, thereby causing delayed repolarization seen as QT interval prolongation on the ECG. Methods and Results - Anti-Ro Ab-positive sera, purified IgG, and affinity-purified anti-52kDa Ro Abs from patients with autoimmune diseases and QTc prolongation were tested on IKr using HEK293 cells expressing HERG channel and native cardiac myocytes. Electrophysiological and biochemical data demonstrate that anti-Ro Abs inhibit IKr to prolong action potential duration by directly binding to the HERG channel protein. The 52-kDa Ro antigen-immunized Guinea pigs showed QTc prolongation on ECG after developing high titers of anti-Ro Abs, which inhibited native IKr and cross-reacted with Guinea pig ERG channel. Conclusions - The data establish that anti-Ro Abs from patients with autoimmune diseases inhibit IKr by cross-reacting with the HERG channel likely at the pore region where homology between anti-52-kDa Ro antigen and HERG channel is present. The animal model of autoimmune-associated QTc prolongation is the first to provide strong evidence for a pathogenic role of anti-Ro Abs in the development of QTc prolongation. It is proposed that adult patients with anti-Ro Abs may benefit from routine ECG screening and that those with QTc prolongation should receive counseling about drugs that may increase the risk for life-threatening arrhythmias.

    AB - Background - Emerging clinical evidence demonstrates high prevalence of QTc prolongation and complex ventricular arrhythmias in patients with anti-Ro antibody (anti-Ro Ab)-positive autoimmune diseases. We tested the hypothesis that anti-Ro Abs target the HERG (human ether-a-go-go-related gene) K+ channel, which conducts the rapidly activating delayed K+ current, IKr, thereby causing delayed repolarization seen as QT interval prolongation on the ECG. Methods and Results - Anti-Ro Ab-positive sera, purified IgG, and affinity-purified anti-52kDa Ro Abs from patients with autoimmune diseases and QTc prolongation were tested on IKr using HEK293 cells expressing HERG channel and native cardiac myocytes. Electrophysiological and biochemical data demonstrate that anti-Ro Abs inhibit IKr to prolong action potential duration by directly binding to the HERG channel protein. The 52-kDa Ro antigen-immunized Guinea pigs showed QTc prolongation on ECG after developing high titers of anti-Ro Abs, which inhibited native IKr and cross-reacted with Guinea pig ERG channel. Conclusions - The data establish that anti-Ro Abs from patients with autoimmune diseases inhibit IKr by cross-reacting with the HERG channel likely at the pore region where homology between anti-52-kDa Ro antigen and HERG channel is present. The animal model of autoimmune-associated QTc prolongation is the first to provide strong evidence for a pathogenic role of anti-Ro Abs in the development of QTc prolongation. It is proposed that adult patients with anti-Ro Abs may benefit from routine ECG screening and that those with QTc prolongation should receive counseling about drugs that may increase the risk for life-threatening arrhythmias.

    KW - antibodies

    KW - arrhythmias cardiac

    KW - immune system

    KW - long QT syndrome

    UR - http://www.scopus.com/inward/record.url?scp=84938587780&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84938587780&partnerID=8YFLogxK

    U2 - 10.1161/CIRCULATIONAHA.115.009800

    DO - 10.1161/CIRCULATIONAHA.115.009800

    M3 - Article

    VL - 132

    SP - 230

    EP - 240

    JO - Circulation

    T2 - Circulation

    JF - Circulation

    SN - 0009-7322

    IS - 4

    ER -